Lykos Therapeutics
About Lykos Therapeutics
Lykos Therapeutics is a biotechnology company focused on developing novel therapies and therapeutic approaches to treat mental health conditions, with an initial emphasis on PTSD. It leverages decades of evidence-based research to catalyze new treatment options and aims to destigmatize conversations around mental health while improving accessibility. As a public benefit corporation, Lykos prioritizes positive impact on patients, communities and society, operating with a global outlook in mental healthcare innovation.
Recent News
Psychedelic Therapy EO Is a Major Step for Mental Health, but Access Barriers Remain, Experts Say
Can an LSD Candidate Do for Anxiety What Spravato Did for Depression?
What Trump’s Psychedelics Executive Order Means for Basic Neuroscience
Psychedelics Space at a ‘Tipping Point’ as Compass, Definium Gear Up To File for Approval
Cassidy Names Areas of Improvement for FDA’s Regulatory ‘Black Box’
Recent Deals
No recent deals for this company.